Skip to main content
OpenTrials

Clinical trial condition

Relapsed Multiple Myeloma

Explore clinical trials studying Relapsed Multiple Myeloma. Study availability and eligibility vary by location and protocol.

27 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Relapsed Multiple Myeloma trial results

Completed

First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)

NCT04083534

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Regeneron Study Site Indianapolis, Indiana, United States
  • Regeneron Study Site Ann Arbor, Michigan, United States
  • Regeneron Study Site Rochester, Minnesota, United States
  • Regeneron Study Site New York, United States
View Trial Details
Completed

A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

NCT05228470

Conditions
BCMA, BCMA-CD3 Bispecific, Bispecific, +23 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View all 15 locations
View Trial Details
Completed

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

NCT03158688

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Lynn Cancer Center Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton, Florida, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Medical Center - Multiple Myeloma Research Consortium Chicago, Illinois, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View all 113 locations
View Trial Details
Completed

A Study of ION251 Administered to Patients With Relapsed/Refractory Multiple Myeloma

NCT04398485

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Rrmc Los Angeles, California, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

A Study Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Or Refractory Multiple Myeloma

NCT04434469

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • LIVERPOOL HOSPITAL; HAEMATOLOGY; Ingham Institute for Medical Research Liverpool, New South Wales, Australia
  • Royal Adelaide Hospital; Haematology Clinical Trials Adelaide, South Australia, Australia
  • St. Vincent's Hospital Melbourne Fitzroy, South Australia, Australia
View Trial Details
Completed

A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

NCT01564537

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • University of Arkansas Medical Sciences Little Rock, Arkansas, United States
  • Pacific Cancer Medical Center Inc Anaheim, California, United States
  • West Contra Costa Healthcare District Berkeley, California, United States
  • University of Florida Gainesville, Florida, United States
View all 24 locations
View Trial Details
Completed

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

NCT01080391

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Providence St. Joseph Medical Center Burbank, California, United States
  • St. Jude Hospital Yorba Linda dba; St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Stanford University Stanford, California, United States
View all 127 locations
View Trial Details

Related conditions